CXCR2 with its ligands shows powerful chemotaxis of neutrophils or myeloid-derived suppressor cell (MDSC) and is related to tumor angiogenesis, progression and chemoresistance [22–26]. This evidence concerns the gene CXCR2 and neoplasm.